SCHEMBL2742995

SCHEMBL2742995

C=C1OC(=O)CC(=O)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16089 0.76
SCHEMBL2554446 0.76
SCHEMBL1669222 0.73
SCHEMBL1696771 0.73 TSHR (0.45)
SCHEMBL14994705 0.72
Water SCHEMBL29008220 0.69 TSHR (0.39)
SCHEMBL7654376 0.69
SCHEMBL17214811 0.69
Itaconic Anhydride SCHEMBL25233 0.69
SCHEMBL322940 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117843633-A Sulfoximine compounds, pharmaceutical compositions and uses thereof 上海海和药物研究开发股份有限公司 2024-04-09 CN disclosed
US-8088794-B2 Substituted amide derivatives and methods of use AMGEN INC. (US) 2012-01-03 US disclosed
US-20110118252-A1 SUBSTITUTED AMIDE DERIVATIVES AND METHODS OF USE AMGEN INC. (US) 2011-05-19 US disclosed
EP-2113510-A1 Pepstatin A derivatives Freie Universität Berlin (DE) 2009-11-04 EP disclosed
US-20080200458-A1 Methods and compositions for the treatment of body composition disorders LEXICON PHARMACEUTICALS, INC. 2008-08-21 US disclosed